Kyntra Bio Inc
KYNB
NASDAQ
Biotechnology
$7.05
USD
+0.01 (+0.14%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $28.50M
Volume 17.7K
Revenue
—
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
—
TTM
— YoY
Operating Cash Flow
—
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2026 |
|---|---|
Revenue | 3.7 |
YoY Growth | — |
Cost of Revenue | 4.1 |
Gross Profit | -0.4 |
Selling, General & Administrative | 5.9 |
Other Operating Expenses | 0.0 |
Total Operating Expenses | 13.5 |
Operating Income | -13.8 |
EBITDA | -13.8 |
Other Income / Expense | 0.0 |
Total Other Income / Expense | -1.3 |
Income Before Income Taxes | -15.1 |
Income Taxes | 0.0 |
Net Income | -15.2 |
Consolidated Net Income / Loss | -15.2 |
Net Income Attributable to Common Shareholders | -15.2 |
Basic EPS | -$3.76 |
Diluted EPS | -$3.76 |
Basic Shares Outstanding | 4.0M |
Diluted Shares Outstanding | 4.0M |